Liver Cancer Antibodies
Liver cancers are the thirteenth highest diagnosed cancer in the United States, with about 2.2% of new cancer cases classified as liver cancer, contributing approx. 4.2% of cancer deaths yearly. As of 2012, there were approximately 51,000 people living with liver cancer in the United States. Those diagnosed with liver cancer have a 5 year survival rate of only 17.2%. Over the last 10 years, rates for new liver cancer cases have been rising on average 4.0% each year while the death rate has not changed significantly. Biocare Medical is proud to offer key liver cancer antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Liver and Intrahepatic Bile Duct Cancer. National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/statfacts/html/livibd.html